Opportunities for Healthy Volunteers
Contribute to medical research by participating in studies designed for healthy participants in your selected area.
↓
Something went wrong, try again later.
Matched clinical trials
Randomized Study of INCB161734 Plus Standard Chemotherapy Drug Combination in Untreated KRAS G12D Metastatic Pancreatic Ductal Adenocarcinoma Patients
Not yet recruiting
3 1 1Investigated Diseases:Investigated Drugs:
+6
Molecularly Tailored Therapy Versus Standard Care in Patients With Advanced Pancreatic Cancer Using Olaparib, Erlotinib, Crizotinib, Trametinib, Pemigatinib, Selpercatinib, Axitinib, Vismodegib, Pembrolizumab, Larotrectinib, Dabrafenib, Capecitabine, Oxaliplatin, Fluorouracil, Irinotecan, Gemcitabine, Paclitaxel Albumin-Bound, and Calcium Folinate
Not yet recruiting
2 1 1 1Investigated Diseases:Investigated Drugs:
Study of M9140 for Patients With Advanced Pancreatic Cancer
Not yet recruiting
1 1 1Investigated Diseases:
Study on Chemotherapy with Liposomal Irinotecan, Oxaliplatin, and 5-Fluorouracil for Patients with Pancreatic Cancer Spread to the Liver
Not yet recruiting
2 1 1 1Investigated Diseases:Investigated Drugs:
Study of Irinotecan with S1 or 5-Fluorouracil for Patients with Metastatic Pancreatic Cancer After Gemcitabine Treatment
Not recruiting
2 1 1 1Investigated Diseases:
Study on Napabucasin, Paclitaxel, and Gemcitabine for Patients with Metastatic Pancreatic Cancer After Chemotherapy Failure
Not recruiting
4 1 1 1Investigated Diseases:Investigated Drugs:
Study on Dostarlimab, Vitamin D3, and Drug Combination for Untreated Metastatic Pancreatic Cancer Patients
Not recruiting
2 1 1 1Investigated Diseases:Investigated Drugs:
Study on Durvalumab and Rintatolimod for Patients with Metastatic Pancreatic Cancer
Not recruiting
1 1 1 1Study on the Safety and Effectiveness of IMM-101 with Radiotherapy for Patients with Limited Metastatic Pancreatic Cancer
Not recruiting
1 1 1Investigated Diseases:Investigated Drugs:


